Andrew Booth
Chief Financial Officer · AbCellera Biologics Inc.
- 2026
- Aug 14, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Booth files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael R. Hayden - $1.05M in ABCL purchases and sales in the last 12 months
- Thermopylae Holdings Ltd. - $711K in ABCL purchases and sales in the last 12 months
- John S. Montalbano - $384K in ABCL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Booth?
Andrew Booth is a corporate insider, tracked as Chief Financial Officer of AbCellera Biologics Inc. (ABCL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew Booth submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Andrew Booth been buying or selling stock?
Recorded transactions: 2 open-market purchases ($530K) and 0 open-market sales across all tracked filings.
